º«¹úÂãÎè is the recipient of a landmark $165 million Canada First Research Excellence Fund (CFREF) grant to launch DNA to RNA: An Inclusive Canadian Approach to Genomic-based RNA Therapeutics (D2R),...
Melanoma accounts for only 1% of skin cancer diagnoses but causes the majority of skin cancer deaths. Two newer types of treatment, targeted therapy and immunotherapy, have shown great benefits for...
This fruitful visit highlighted the GCI's breast cancer research advances and discoveries thanks to the biological materials, data banks and significant fundings from QBCF and RRCancer. Their...
In this workshop, students learned about how we do research and how it can lead to advances in the clinic. They visited our research laboratories and participated in hands-on activities. Throughout...